secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001213900-24-109347
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Court approves Bionomics' re-domiciliation; Neuphoria to list Dec 24 under NEUP
-------------------------------------------------------------------------------

- Supreme Court of NSW approved Scheme of Arrangement on Dec 16, 2024; scheme became legally effective after lodgment with ASIC.
- Bionomics ADSs trade on Nasdaq through Dec 23, 2024; shareholders as of Dec 17 record date receive scheme consideration.
- Neuphoria Therapeutics Inc. shares expected to begin trading on Nasdaq under "NEUP" on Dec 24, 2024.
- Bionomics will become wholly-owned subsidiary of Neuphoria, re-domiciling from Australia to Delaware.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024109347/0001213900-24-109347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024109347/ea0224864-8k_bionomics.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-109347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer